8/2/2017 radiomics in clinical...

6
8/2/2017 1 Radiomics in Clinical Trials Laurence Court Departments of Radiation Oncology and Imaging Physics University of Texas MD Anderson Cancer Center Conflicts of Interest Radiomics projects funded by the NCI Other projects funded by the NCI, CPRIT, Varian, Elekta 2 Significant growth in radiomics Figure from Philippe Lambin, MAASTRO

Upload: others

Post on 22-May-2020

3 views

Category:

Documents


0 download

TRANSCRIPT

8/2/2017

1

Radiomics in Clinical Trials Laurence Court

Departments of Radiation Oncology and Imaging Physics

University of Texas MD Anderson Cancer Center

Conflicts of Interest

• Radiomics projects funded by the NCI

• Other projects funded by the NCI, CPRIT, Varian, Elekta

2

Significant growth in radiomics

Figure from Philippe Lambin, MAASTRO

8/2/2017

2

Goals of radiomics studies

Buckler, et al., A Collaborative Enterprise for Multi-Stakeholder Participation in the Advancement of Quantitative Imaging, Radiology 258:906-914, 2011

Based slides from Xenia Fave and Ed Jackson

General Radiomics Hypothesis: Quantitative image features are related to underlying gene expression and phenotype

4

Classifing Tumors

• Benign v. Malignant, Wang 2010

• SCC v. ACC, Basu 2011

Predicting Outcomes

• Aerts 2014 • Fried 2015

Links to Genomics

• K-ras mutant, Weiss 2014

• MAPK pathway, Miles 2016

Monitoring Response

• Fave 2017

Imaging biomarker roadmap

Figure from O’Connor et al., Nat Rev Clin Oncol 14(3), 169-186, 2017

Radiomics for prospective trials • Radiomics takes advantage of imaging that is happening anyway!

• Sufficiently advanced that we should be planning radiomics studies for all prospective trials • Embed in protocol (e.g. as secondary endpoint)

• Additional QA for radiomics aspects of the trial

Treatment delivery accreditation by IROC-Houston ACR CT phantom

8/2/2017

3

Radiomics workflow

Figure adapted from Aerts et al, Nature Communications 2015

Imaging Pre-processing Feature extraction Analysis Segmentation

Includes: • Imaging protocol • Motion

management

7

Including feature selection

Imaging protocols should be harmonized • Texture phantom

• Acquired 17 scans from GE, Philips, Siemens and Toshiba scanners scattered throughout the Texas Medical Center

Dennis Mackin et al, Investigative Radiology 50(11), 757-765, 2015 Data from Dennis Mackin

Harmonization of PET imaging

Harmonize protocols

Figures from Robert Jeraj, University of Wisconsin. Also see Lin et al, JNM 2016

• Two scanners: Discovery (GE) and Gemini (Philips) • Harmonize GE scanner to the Philips scanner

9

8/2/2017

4

Minimize inter-scanner variability

• Minimize the number of scanners (to one…..) • Aerts et al, Defining a Radiomics Response

Phenotype: A Pilot Study using targeted therapy in NSCLC, Scientific Reports 6, 33860, 2016 • 47 patients • Radiomics data could predict EGFR-mutation status

and associated gefitinib response

• Minimize the number of scanners (to a few) • Fried et al, Prognostic Value and Reproducibility

of Pretreatment CT texture features in stage III non-small cell lung cancer, IJROBP 90(4), 834-842, 2014

But care is still needed…….. • 110 NSCLC patients with advanced stage disease

• Randomized to treatment with IMRT or PSPT to 66 or 74 Gy

• Received concurrent chemotherapy

• Imaged with a 4DCT weekly during treatment (5-9 4DCTs per patient)

• Most on one of two CT scanners (both GE, one was widebore, one was PET-CT)

• Texture signature was a function of CT scanner

Data from Xenia Fave, UT MD Anderson Cancer Center (published in Scientific Reports 7, 588, 2017 11

CT Model Dependence can be mitigated by image preprocessing • Scanner independence, p-value of Wilcoxon rank sum test

• No features were ALWAYS significantly associated with CT model

• Suggests that image preprocessing can be used to remove differences between CT scanners

• 24 features were ALWAYS independent of CT model

• Included features from all 4 categories

• For 31 features that were sometimes dependent,

• 2 features were fixed with bit depth resampling

• 28 features with smoothing

• 27 with smoothing and bit depth resampling

• 6 no preprocessing

12

+

8/2/2017

5

Radiomics workflow

Figure adapted from Aerts et al, Nature Communications 2015

Imaging Pre-processing Feature extraction Analysis Segmentation

Includes: • Imaging protocol • Motion

management

13

Including feature selection

Segmentation

Based on Hunter et al, Med Phys 40, 121916, 2013 14

Increasing pixel removal

• PET texture – tracer uptake heterogeneity: • Metabolism • Hypoxia • Cellular proliferation • Vascularization • Necrosis

• CT texture - tissue density heterogeneity: • Vascularization • Necrosis • Relative fat, air, water content

• But - we don’t understand the meaning of the radiomics texture features in terms of pathophysiology

• Reproducibility/robustness is important • If using pre-drawn contours, consider the original task

Hatt et al, Eur J Nucl Mol Imaging, 2016

• Benchmark standards (standard images etc) • Open source algorithms • Standardization

• Phantoms • Best (consensus) practices • Accurate reporting • Data sharing 15

8/2/2017

6

Resources • Court et al, Computational resources for radiomics, Translational Cancer Research 5(4), 340-348, 2016

• Larue et al, Quantitative radiomics studies for tissue characterization: A review of technology and methodological procedures, Brit. J. Radiol. 90, 20160665, 2017

• www.Radiomics.world – Radiomics Quality Score

www.radiomics.world

Final thoughts • Radiomics:

• Is correlated to biology

• Can improve accuracy of prediction

• Can calculate probability of certain diagnosis

• Can be used in clinical trials

• (and is low cost and non-invasive)

• Re-analyse your image data whenever possible

• Plan radiomics studies in all your prospective trials

• Embed radiomics studies into the protocol (e.g. as a secondary endpoint or hypothesis generative approach monitoring treatment response)

• Careful consideration of the imaging protocols

• Full transparency on everything else

• Imaging

• Feature extraction (details)

• Analysis

Partially based on slides by Philippe Lambin, MAASTRO Fried et al, IJROBP 94, 368-376, 2015

Research group and collaborators

Our group (past and present)

• Joy Zhang

• Jinzhong Yang

• Dennis Mackin

• Luke Hunter

• David Fried

• Xenia Fave

• Joonsang Lee

• Rachel Ger

Physics

• Osama Mawlawi

• Peter Balter

Radiation Oncology and Radiology

• Zhongxing Liao

• Steven Lin

• Daniel Gomez

• Chaan Ng

• Joe Chang

• Dave Fuller

Statistics

• Shouhao Zhou

• Susan Tucker

• Francesco Stingo

• Arvind Rao

• Center for Radiation Oncology Research 18